๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies

โœ Scribed by Bernd Franke; Tamara S. Galloway; Terry J. Wilkin


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
342 KB
Volume
21
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

โœฆ Synopsis


The prodromal phase of type 1 diabetes is characterised by the appearance of multiple islet-cell related autoantibodies (Aab). The major target antigens are islet-cell antigen, glutamic acid decarboxylase (GAD), protein-tyrosine phosphatase-2 (IA-2) and insulin. Insulin autoantibodies (IAA), in contrast to the other autoimmune markers, are the only ฮฒ-cell specific antibodies. There is general consensus that the presence of multiple Aab (โ‰ฅ 3) is associated with a high risk of developing diabetes, where the presence of a single islet-cell-related Aab has usually a low predictive value. The most commonly used assay format for the detection of Aab to GAD, IA-2 and insulin is the fluid-phase radiobinding assay. The RBA does not identify or measure Aab, but merely detects its presence. However, on the basis of molecular studies, disease-specific constructs of GAD and IA-2 have been employed leading to somewhat improved sensitivity and specificity of the RBA. Serological studies have shown epitope restriction of IAA that can differentiate diabetes-related from unrelated IAA, but current assays do not distinguish between disease-predictive and non-predictive IAA or between IAA and insulin antibodies (IA). More recently, phage display technology has been successful in identifying disease-specific anti-idiotopes of insulin. In addition, phage display has facilitated the in vitro production of antibodies with high affinity. Identification of disease-specific anti-idiotopes of insulin should enable the production of a high affinity reagent against the same anti-idiotope. Such a development would form the basis of a disease-specific radioimmunoassay able to identify and measure particular idiotypes, rather than merely detect and titrate IAA.


๐Ÿ“œ SIMILAR VOLUMES


Pravastatin compared to bezafibrate in t
โœ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 2 views

Background Both HMG-CoA reductase inhibitors and ยฎbric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg bezaยฎbrate, a ยฎbric acid deriva

Parameters associated with residual insu
โœ Bonfanti, R.; Bazzigaluppi, E.; Calori, G.; Riva, M.C.; Viscardi, M.; Bognetti, ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

Factors associated with residual insulin secretion and spontaneous remission in Type 1 diabetic patients are important in the evaluation of treatment aimed at modifying the natural history of Type 1 DM. We investigated the effect of parameters at onset on residual beta cell function in 215 Type 1 DM

Autoantibodies to GAD, IA-2 and insulin
โœ Sari Korhonen; Maria M. Knip; Petri Kulmala; Kaisa Savola; Hans K. ร…kerblom; Mik ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB

## Abstract ## Background Islet cell antibodies (ICA) represent a heterogenous group of autoantibodies to diabetesโ€associated antigens, including glutamic acid decarboxylase (GAD) and the IAโ€2 protein. The objectives of the present study were to compare the prevalence of autoantibodies to known bi

Neurovascular relationships in the poste
โœ Peter J. Hamlyn ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 401 KB ๐Ÿ‘ 2 views

Vascular compression of cranial nerves adjacent to the brain stem has been implicated in a wide variety of disorders affecting their function. The considerable conflicts in published results relate primarily to flaws in study design. The design required of an adequate study is defined and a techniqu